--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
APTO Aptose Biosciences
- 0.2790
- +0.1088+63.92%
Close Dec 20 16:00 ET
- 0.2250
- -0.0540-19.35%
Post 20:01 ET
16.61MMarket Cap-0.10P/E (TTM)
0.3895High0.2106Low306.25MVolume0.2700Open0.1702Pre Close94.96MTurnover543.67%Turnover RatioLossP/E (Static)59.52MShares2.680052wk High-1.82P/B15.72MFloat Cap0.130052wk Low--Dividend TTM56.33MShs Float1457.9988Historical High--Div YieldTTM105.11%Amplitude0.1300Historical Low0.3100Avg Price1Lot Size
Aptose Biosciences Key Stats
Aptose Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Aptose Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
